Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis
Objective To evaluate the efficacy and safety of Secukinumab versus Adalimumab in the treatment of the moderate to severe plaque psoriasis. Methods A total of 90 patients with moderate to severe psoriasis were randomly divided into three groups: Secukinumab group (30 patients), Adalimumab (29 patien...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2023-06-01
|
| Series: | Pifu-xingbing zhenliaoxue zazhi |
| Assuntos: | |
| Acceso en liña: | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.03.011 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|